The assessment of future RSV immunizations: How to protect all infants?

The assessment of future RSV immunizations: How to protect all infants?

Bibliographic Details
Main Authors:	Louis Bont, Catherine Weil Olivier, Egbert Herting, Susanna Esposito, Jose Antonio Navarro Alonso, Federico Lega, Silke Mader, Ichiro Morioka, Kunling Shen, George A. Syrogiannopoulos, Saul N. Faust, Elena Bozzola
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Pediatrics
Subjects:	infant and child health infant mortality respiratory syncytial virus (RSV) RSV-acute lower respiratory illness monoclonal antibody infant hospitalization
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2022.981741/full

Similar Items

RSV: perspectives to strengthen the need for protection in all infants
by: Jose Antonio Navarro Alonso, et al.
Published: (2021-10-01)

RSV disease in infants and young children: Can we see a brighter future?
by: Eugenio Baraldi, et al.
Published: (2022-11-01)

Clinical and economic burden of respiratory syncytial virus in children aged 0–5 years in Italy
by: Melania Dovizio, et al.
Published: (2024-03-01)

RSV Disease Threat and Innovative Prevention Methods in Health Protection: A Review
by: Paulina Dąbrowska, et al.
Published: (2024-02-01)

Epidemiology and molecular characteristics of respiratory syncytial virus (RSV) among italian community-dwelling adults, 2021/22 season
by: Donatella Panatto, et al.
Published: (2023-03-01)

Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
by: Mark H. Rozenbaum, et al.
Published: (2023-01-01)

Epidemiology and prevention of respiratory syncytial virus infections in children in Italy
by: Chiara Azzari, et al.
Published: (2021-10-01)

IRIS: Infection with RespIratory Syncytial Virus in infants—a prospective observational cohort study
by: Martin Wetzke, et al.
Published: (2022-03-01)

Epidemiology and Seasonality of Childhood Respiratory Syncytial Virus Infections in the Tropics
by: Manika Suryadevara, et al.
Published: (2021-04-01)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
by: Jackelyn Murray, et al.
Published: (2022-04-01)

Inhaled “Muco‐Trapping” Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections
by: Morgan D. McSweeney, et al.
Published: (2024-03-01)

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
by: Mark R. Ackermann, et al.
Published: (2012-10-01)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
by: Freek Cox, et al.
Published: (2023-03-01)

Critical care of severe bronchiolitis during shortage of ICU resources
by: Daniele De Luca, et al.
Published: (2024-03-01)

Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians
by: Matteo Riccò, et al.
Published: (2023-02-01)

Going Viral—RSV as the Neglected Adult Respiratory Virus
by: Bethany Busack, et al.
Published: (2022-11-01)

Maternal RSV vaccine development. Where to from here?
by: Ahinsa Gunatilaka, et al.
Published: (2021-11-01)

Prophylaxis protects infants with congenital heart disease from severe forms of RSV infection: an Italian observational retrospective study
by: Chiara Ratti, et al.
Published: (2023-01-01)

Immunopathology of RSV: An Updated Review
by: Harrison C. Bergeron, et al.
Published: (2021-12-01)

Human Respiratory Syncytial Virus Memphis 37 Grown in HEp-2 Cells Causes more Severe Disease in Lambs than Virus Grown in Vero Cells
by: Rachel J. Derscheid, et al.
Published: (2013-11-01)

Mutation of Respiratory Syncytial Virus G Protein’s CX3C Motif Attenuates Infection in Cotton Rats and Primary Human Airway Epithelial Cells
by: Binh Ha, et al.
Published: (2019-07-01)

Mucosal Immune Responses to Respiratory Syncytial Virus
by: Megan V. C. Barnes, et al.
Published: (2022-03-01)

Psychometric evaluation of the respiratory syncytial virus infection, intensity and impact questionnaire (RSV-iiiQ) in adults
by: Valerie Williams, et al.
Published: (2024-02-01)

Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus
by: Bo-Wen Sun, et al.
Published: (2024-01-01)

A Contemporary View of Respiratory Syncytial Virus (RSV) Biology and Strain-Specific Differences
by: Mansi C. Pandya, et al.
Published: (2019-05-01)

Palivizumab prophylaxis of RSV infections in Bosnia and Herzegovina
by: Suada Heljic, et al.
Published: (2016-02-01)

Respiratory Syncytial Virus Matrix Protein Is Sufficient and Necessary to Remodel Host Mitochondria in Infection
by: MengJie Hu, et al.
Published: (2023-05-01)

Palivizumab e virus respiratorio sinciziale: una panoramica
by: Paolo Manzoni
Published: (2011-07-01)

Probing In Silico the Benzimidazole Privileged Scaffold for the Development of Drug-like Anti-RSV Agents
by: Elena Cichero, et al.
Published: (2021-12-01)

Update on respiratory syncytial virus hospitalizations among U.S. preterm and term infants before and after the 2014 American Academy of Pediatrics policy on immunoprophylaxis: 2011-2017
by: Jaime Fergie, et al.
Published: (2021-05-01)

Unnecessary antibiotic treatment of children hospitalised with respiratory syncytial virus (RSV) bronchiolitis: risk factors and prescription patterns
by: Uri Obolski, et al.
Published: (2021-12-01)

Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis
by: Brian M. Maas, et al.
Published: (2021-11-01)

Clinical Differences between SARS-CoV-2 and RSV Infections in Infants: Findings from a Case–Control Study
by: Victor Daniel Miron, et al.
Published: (2023-12-01)

Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities
by: Jintanat Ananworanich, et al.
Published: (2021-08-01)

Prospective Attitudes towards Respiratory Syncytial Virus (RSV) Vaccination: Validation of a Survey Instrument among Young Females in Jordan Pending Vaccine Authorization
by: Tleen Kherfan, et al.
Published: (2023-08-01)

Chimeric Measles Virus (MV/RSV), Having Ectodomains of Respiratory Syncytial Virus (RSV) F and G Proteins Instead of Measles Envelope Proteins, Induced Protective Antibodies against RSV
by: Akihito Sawada, et al.
Published: (2021-02-01)

Hospitalisation of late preterm infants due to lower respiratory tract infections in Lithuania, Latvia, and Estonia: incidence, disease severity, and risk factors
by: Nijolė Drazdienė, et al.
Published: (2018-08-01)

Epidemiology and molecular analyses of respiratory syncytial virus in the 2021–2022 season in northern Italy
by: Alessia Lai, et al.
Published: (2024-01-01)

Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity
by: Nita Patel, et al.
Published: (2020-10-01)

Development and comparison of immunologic assays to detect primary RSV infections in infants
by: Larry J. Anderson, et al.
Published: (2024-01-01)